e-learning
resources
London 2016
Sunday, 04.09.2016
IPF: from pathogenesis to treatment I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New therapies in IPF: The Hammersmith Hospital experience
Robina K. Coker (London, United Kingdom), Robina K. Coker, Philip W. Ind
Source:
International Congress 2016 – IPF: from pathogenesis to treatment I
Session:
IPF: from pathogenesis to treatment I
Session type:
Thematic Poster
Number:
784
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robina K. Coker (London, United Kingdom), Robina K. Coker, Philip W. Ind. New therapies in IPF: The Hammersmith Hospital experience. Eur Respir J 2016; 48: Suppl. 60, 784
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Survival in CVD-ILD at Ege University Hospital
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Clinical study of pediatric interstitial lung diseases in China
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Inspiration: An assistance program for idiopathic pulmonary fibrosis patients on pirfenidone
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014
12 years of thoracic surgery for emphysema at The Royal Brompton Hospital
Source: Annual Congress 2013 –Surgery for pleuropulmonary and mediastinal benign diseases
Year: 2013
Audit investigating self-management of bronchiectasis at University Hospital Llandough, Wales
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Dedicated Pulmonary Rehabilitation for Patients with Interstitial Lung Disease in a District General Hospital
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
Diagnosis, treatment and doctor delays in lung cancer patients who had diagnostic fiberoptic bronchoscopy at Pamukkale University Pulmonary Diseases Clinic
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
District General Hospital experience with indwelling pleural catheters(IPC); in-patient and outpatient management
Source: International Congress 2014 – The planet of the pleura
Year: 2014
Oncologic emergencies in patients monitored for lung cancer in the Bab-El-Oued University Hospital
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Eosinophilic pulmonary syndromes: Retrospective study of the past 18 years in Coimbra University Hospital
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
Paediatric interstitial lung disease
Source: Eur Respir Mon; 2009: 46: 319–354
Year: 2009
Paediatric interstitial lung disease
Source: ERS Course 2016
Year: 2016
Infant interstitial lung disease: Review of our experience
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Quality of life in cystic fibrosis patients at Cork University Hospital
Source: Eur Respir J 2006; 28: Suppl. 50, 317s
Year: 2006
The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Source: International Congress 2014 – ILDs 4
Year: 2014
Clinical profile of hepatic patients with pleural complications admitted to Sohag University Hospital
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Clinical characteristics of familial Idiopathic Pulmonary Fibrosis (f-IPF) at the University of Giessen Marburg Lung Center.
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Use of a rapid access email referral system in lung cancer: Diagnosing Cancer Earlier?North Edinburgh Lung cancer service Western General Hospital
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept